✦ LIBER ✦

RSV-induced cell transformation: Effect of protease inhibitors on fibronectin and plasminogen activators

✍ Scribed by De Petro, G.; Bellotti, D.; Barlati, S.

Book ID: 122364729
Publisher: Elsevier Science
Year: 1987
Weight: 121 KB
Volume: 23
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(87)90523-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterisation of fibronectin fragment

Characterisation of fibronectin fragments and plasminogen activators released by RSV-transformed cells

✍ De Petro, G.; Barlati, S. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 579 KB

Inhibitory Effect of Protease Inhibitor

Inhibitory Effect of Protease Inhibitor on Endothelial Cell Activation

✍ Suefumi Aosasa; Satoshi Ono; Shuhji Seki; Eiji Takayama; Takushi Tadakuma; Hoshi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Effects and mechanism of tissue-type pla

Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation

✍ Ma Xiaoli; Huang Wenying; She Mingpeng 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Effect of Tisseel® on expression of tiss

Effect of Tisseel® on expression of tissue plasminogen activator and plasminogen activator inhibitor-1

✍ Michael P. Diamond; Michael Kruger; Ghassan M. Saed 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Cytoprotective effect of protease inhibi

Cytoprotective effect of protease inhibitors of endothelial cell injury induced by activated leukocytes

✍ Hiroshi Fujita; Ikuo Morita; Seiitsu Murota 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Effect of oral defibrotide on tissue-pla

Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance

✍ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done